Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Relation of Statin Use and Mortality in Community-Dwelling Frail Older Patients With Coronary Artery Disease

A. Pilotto, P. Gallina, F. Panza, M. Copetti, A. Cella, A. Cruz-Jentoft, J. Daragjati, L. Ferrucci, S. Maggi, F. Mattace-Raso, M. Paccalin, MC. Polidori, E. Topinkova, G. Trifirò, AK. Welmer, T. Strandberg, N. Marchionni, . ,

. 2016 ; 118 (11) : 1624-1630. [pub] 20160830

Language English Country United States

Document type Journal Article, Multicenter Study, Observational Study

Persistent link   https://www.medvik.cz/link/bmc17023679
E-resources Online Full text

NLK ProQuest Central from 2012-08-15 to 2 months ago
Nursing & Allied Health Database (ProQuest) from 2012-08-15 to 2 months ago
Health & Medicine (ProQuest) from 2012-08-15 to 2 months ago

Links

PubMed 27670793
DOI 10.1016/j.amjcard.2016.08.042
Knihovny.cz E-resources

Clinical decision-making for statin treatment in older patients with coronary artery disease (CAD) is under debate, particularly in community-dwelling frail patients at high risk of death. In this retrospective observational study on 2,597 community-dwelling patients aged ≥65 years with a previous hospitalization for CAD, we estimated mortality risk assessed with the Multidimensional Prognostic Index (MPI), based on the Standardized Multidimensional Assessment Schedule for Adults and Aged Persons (SVaMA), used to determine accessibility to homecare services/nursing home admission in 2005 to 2013 in the Padua Health District, Veneto, Italy. Participants were categorized as having mild (MPI-SVaMA-1), moderate (MPI-SVaMA-2), and high (MPI-SVaMA-3) baseline mortality risk, and propensity score-adjusted hazard ratios (HRs) of 3-year mortality rate were calculated according to statin treatment in these subgroups. Greater MPI-SVaMA scores were associated with lower rates of statin treatment and higher 3-year mortality rate (MPI-SVaMA-1 = 23.4%; MPI-SVaMA-2 = 39.1%; MPI-SVaMA-3 = 76.2%). After adjusting for propensity score quintiles, statin treatment was associated with lower 3-year mortality risk irrespective of MPI-SVaMA group (HRs [95% confidence intervals] 0.45 [0.37 to 0.55], 0.44 [0.36 to 0.53], and 0.28 [0.21 to 0.39] in MPI-SVaMA-1, -2, and -3 groups, respectively [interaction test p = 0.202]). Subgroup analyses showed that statin treatment was also beneficial irrespective of age (HRs [95% confidence intervals] 0.38 [0.27 to 0.53], 0.45 [0.38 to 0.54], and 0.44 [0.37 to 0.54] in 65 to 74, 75 to 84, and ≥85 year age groups, respectively [interaction test p = 0.597]). In conclusion, in community-dwelling frail older patients with CAD, statin treatment was significantly associated with reduced 3-year mortality rate irrespective of age and multidimensional impairment, although the frailest patients were less likely to be treated with statins.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023679
003      
CZ-PrNML
005      
20170830102209.0
007      
ta
008      
170720s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.amjcard.2016.08.042 $2 doi
035    __
$a (PubMed)27670793
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Pilotto, Alberto $u Department of Geriatric Care, OrthoGeriatrics and Rehabilitation, Frailty Area, E.O. Galliera Hospital, National Relevance and High Specialization Hospital, Genoa, Italy; Geriatrics Unit, Azienda ULSS 16 Padova, S. Antonio Hospital, Padua, Italy.
245    10
$a Relation of Statin Use and Mortality in Community-Dwelling Frail Older Patients With Coronary Artery Disease / $c A. Pilotto, P. Gallina, F. Panza, M. Copetti, A. Cella, A. Cruz-Jentoft, J. Daragjati, L. Ferrucci, S. Maggi, F. Mattace-Raso, M. Paccalin, MC. Polidori, E. Topinkova, G. Trifirò, AK. Welmer, T. Strandberg, N. Marchionni, . ,
520    9_
$a Clinical decision-making for statin treatment in older patients with coronary artery disease (CAD) is under debate, particularly in community-dwelling frail patients at high risk of death. In this retrospective observational study on 2,597 community-dwelling patients aged ≥65 years with a previous hospitalization for CAD, we estimated mortality risk assessed with the Multidimensional Prognostic Index (MPI), based on the Standardized Multidimensional Assessment Schedule for Adults and Aged Persons (SVaMA), used to determine accessibility to homecare services/nursing home admission in 2005 to 2013 in the Padua Health District, Veneto, Italy. Participants were categorized as having mild (MPI-SVaMA-1), moderate (MPI-SVaMA-2), and high (MPI-SVaMA-3) baseline mortality risk, and propensity score-adjusted hazard ratios (HRs) of 3-year mortality rate were calculated according to statin treatment in these subgroups. Greater MPI-SVaMA scores were associated with lower rates of statin treatment and higher 3-year mortality rate (MPI-SVaMA-1 = 23.4%; MPI-SVaMA-2 = 39.1%; MPI-SVaMA-3 = 76.2%). After adjusting for propensity score quintiles, statin treatment was associated with lower 3-year mortality risk irrespective of MPI-SVaMA group (HRs [95% confidence intervals] 0.45 [0.37 to 0.55], 0.44 [0.36 to 0.53], and 0.28 [0.21 to 0.39] in MPI-SVaMA-1, -2, and -3 groups, respectively [interaction test p = 0.202]). Subgroup analyses showed that statin treatment was also beneficial irrespective of age (HRs [95% confidence intervals] 0.38 [0.27 to 0.53], 0.45 [0.38 to 0.54], and 0.44 [0.37 to 0.54] in 65 to 74, 75 to 84, and ≥85 year age groups, respectively [interaction test p = 0.597]). In conclusion, in community-dwelling frail older patients with CAD, statin treatment was significantly associated with reduced 3-year mortality rate irrespective of age and multidimensional impairment, although the frailest patients were less likely to be treated with statins.
650    _2
$a činnosti denního života $7 D000203
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    12
$a klinické rozhodování $7 D000066491
650    _2
$a nemoci koronárních tepen $x farmakoterapie $x mortalita $7 D003324
650    _2
$a ženské pohlaví $7 D005260
650    12
$a křehký senior $7 D016330
650    _2
$a geriatrické hodnocení $x metody $7 D015577
650    12
$a ukazatele zdravotního stavu $7 D006305
650    _2
$a lidé $7 D006801
650    _2
$a statiny $x terapeutické užití $7 D019161
650    _2
$a Itálie $x epidemiologie $7 D007558
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a prognóza $7 D011379
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a rizikové faktory $7 D012307
650    _2
$a míra přežití $x trendy $7 D015996
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Gallina, Pietro $u Health Directorate, Azienda ULSS 16, Padua, Italy.
700    1_
$a Panza, Francesco $u Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy. Electronic address: geriat.dot@geriatria.uniba.it.
700    1_
$a Copetti, Massimiliano $u Unit of Biostatistics, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy.
700    1_
$a Cella, Alberto $u Department of Geriatric Care, OrthoGeriatrics and Rehabilitation, Frailty Area, E.O. Galliera Hospital, National Relevance and High Specialization Hospital, Genoa, Italy.
700    1_
$a Cruz-Jentoft, Alfonso $u Hospital Universitario Ramòn y Cajal, Madrid, Spain.
700    1_
$a Daragjati, Julia $u Geriatrics Unit, Azienda ULSS 16 Padova, S. Antonio Hospital, Padua, Italy.
700    1_
$a Ferrucci, Luigi $u National Institute on Aging, Baltimore, Maryland.
700    1_
$a Maggi, Stefania $u National Research Council, Neuroscience Section, Padua, Italy.
700    1_
$a Mattace-Raso, Francesco $u Erasmus Medical Center, Rotterdam, The Netherlands.
700    1_
$a Paccalin, Marc $u University Hospital of Poitiers, Poitiers, France.
700    1_
$a Polidori, Maria Cristina $u Unit for Aging Clinical Research, Department of Medicine II, University of Cologne, Cologne, Germany.
700    1_
$a Topinkova, Eva $u University Charles I, Prague, Czech Republic.
700    1_
$a Trifirò, Gianluca $u Erasmus Medical Center, Rotterdam, The Netherlands; University of Messina, Messina, Italy.
700    1_
$a Welmer, Anna-Karin $u Aging Research Center, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Strandberg, Timo $u Geriatric Clinic, Department of Medicine, University of Helsinki, Helsinki, Finland; Institute of Health Sciences/Geriatrics, University of Oulu, and Oulu University Hospital, Oulu, Finland.
700    1_
$a Marchionni, Niccolò $u Division of Geriatric Cardiology and Medicine, University of Florence, Florence, Italy.
700    1_
$a ,
773    0_
$w MED00000236 $t The American journal of cardiology $x 1879-1913 $g Roč. 118, č. 11 (2016), s. 1624-1630
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27670793 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170830102757 $b ABA008
999    __
$a ok $b bmc $g 1239360 $s 984592
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 118 $c 11 $d 1624-1630 $e 20160830 $i 1879-1913 $m The American journal of cardiology $n Am J Cardiol $x MED00000236
LZP    __
$a Pubmed-20170720

Find record

Citation metrics

Archiving options